Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going.
And here is our regular feature in which we highlight a different person each week. This time around, we note that Alloy Therapeutics hired Venkat Krishnamurthy as chief scientific officer of its genetic medicines division. Previously, he held the same role at Flashpoint Therapeutics.
But all work and no play can make for a dull chief scientific officer.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in
